TechNavio today launched its report Global Kidney Cancer Drugs 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The vendors in this market are investing heavily in R&D to develop kidney cancer drugs from biological sources because this approach can increase the efficacy of the drugs. Moreover, vendors are formulating effective injection solutions that can help retain the efficacy of the drug molecule for a longer period. For instance, Pfizer Inc. is increasingly focusing on enhancing the efficacy of its kidney cancer drug Sutent. Moreover, vendors are increasing their investment in the R&D of drugs that can be used for the treatment of more than one type of cancer.”
According to the report, the US government has increased expenditure on healthcare because of the prevalence of several diseases, which are largely due to the changing lifestyles of individuals, environmental health hazards, and genetic disorders. As a result, the use of therapeutic drugs for the treatment of cancer has increased. Healthcare spending in the US has increased significantly. Thus, the opportunity for revenue generation has increased, which acts as a driver of the Kidney Cancer Drugs market in the US. Moreover, this increase in healthcare expenditure is expected to increase the quality of treatments as well as the number of R and D projects. This is one of the major drivers contributing to the growth of the Global Kidney Cancer Drugs market
.
Further, the report states that the delay in diagnosing cancer is one of the major challenges in the Global Kidney Cancer Drugs market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-kidney-cancer-drugs-market-2012-…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Global Kidney Cancer Drugs Market 2012-2016
